Merit Medical Systems, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on October 29, 2026, reporting third-quarter net income of $42.3 million on net sales of $416.2 million.

Key Highlights

  • Net sales: $416,244 thousand for the three months ended September 30, 2026, compared to $384,157 thousand in the same period of 2025.
  • Net income: $42,311 thousand for Q3 2026, up from $27,755 thousand in Q3 2025.
  • Diluted EPS: $0.70 for the three months ended September 30, 2026, versus $0.46 for the same period in 2025.
  • Nine-month net sales: $1,216,964 thousand for the nine months ended September 30, 2026, compared to $1,121,970 thousand for the same period in 2025.
  • Total assets: $2,924,906 thousand as of September 30, 2026, up from $2,685,922 thousand as of December 31, 2025.
  • Cash and cash equivalents: $503,551 thousand as of September 30, 2026, compared to $446,404 thousand as of December 31, 2025.
  • Shares outstanding: 59,915,044 shares of common stock as of October 27, 2026.

Merit Medical Systems Reports Q3 2026 Financial Results

According to the filing, Merit Medical Systems (NASDAQ:MMSI) recorded net sales of $416,244 thousand for the three months ended September 30, 2026, an increase from $384,157 thousand in the comparable prior-year quarter. Gross profit for the quarter was $200,631 thousand, up from $186,411 thousand a year earlier. Income from operations reached $58,763 thousand for Q3 2026, compared to $42,612 thousand for Q3 2025, the company disclosed.

For the nine months ended September 30, 2026, the filing reported net sales of $1,216,964 thousand versus $1,121,970 thousand for the same period in 2025. Nine-month net income was $122,109 thousand, compared to $90,483 thousand for the first nine months of 2025. Diluted earnings per share for the nine-month period were $2.03, against $1.49 in the prior-year period, according to the filing.

On the balance sheet, the company reported total assets of $2,924,906 thousand as of September 30, 2026, compared to $2,685,922 thousand as of December 31, 2025. Long-term debt stood at $737,404 thousand, and total stockholders' equity was $1,744,551 thousand as of the quarter-end date, the filing stated. Inventories increased to $391,022 thousand from $333,705 thousand at December 31, 2025. Goodwill was reported at $537,135 thousand as of September 30, 2026, up from $506,837 thousand at year-end 2025.

What Was Disclosed

Merit Medical Systems filed its quarterly report covering the period ended September 30, 2026, disclosing third-quarter net sales of $416,244 thousand, net income of $42,311 thousand, diluted EPS of $0.70, and total assets of $2,924,906 thousand, with 59,915,044 shares outstanding as of October 27, 2026.